📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Alumis

1.1 - Company Overview

Alumis Logo

Alumis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of precision medicine solutions focused on the discovery, development, and treatment of autoimmune disorders.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Alumis

One Lambda Logo

One Lambda

HQ: United States Website
  • Description: Provider of histocompatibility (HLA) typing tests using serological and molecular technologies, and manufacturer of antibody detection products, laboratory instrumentation, and computer software used to simplify and automate testing procedures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full One Lambda company profile →
Escient Pharmaceuticals Logo

Escient Pharmaceuticals

HQ: United States Website
  • Description: Provider of bio-technical research and development services focused on advancing first-in-class G Protein-Coupled Receptor targeted drugs and therapies for neuro-immuno-inflammatory and autoreactive diseases. Pipeline includes EP262, an oral, once-daily small molecule MRGPRX2 antagonist for the potential treatment of mast cell-mediated diseases (including chronic urticarias and atopic dermatitis), and EP547, an oral, once-daily MRGPRX4 antagonist for cholestatic and uremic pruritus.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Escient Pharmaceuticals company profile →
Septerna Logo

Septerna

HQ: United States Website
  • Description: Provider of GPCR-focused drug discovery platforms and services, including a Native Complex Platform that reproduces receptors outside cells, enabling discovery for previously undruggable GPCRs; GPCR affinity screening; structural biology using cryo-EM; and in silico screening, plus small-molecule discovery programs targeting well-validated GPCRs across multiple therapeutic areas.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Septerna company profile →
vTv Therapeutics Logo

vTv Therapeutics

HQ: United States Website
  • Description: Provider of small-molecule therapeutics addressing unmet medical needs, including: TTP399, a liver-selective glucokinase activator adjunct to insulin for type 1 diabetes to reduce hypoglycemia; HPP737, a PDE4 inhibitor for psoriasis with potential in COPD and atopic dermatitis; TTP273, an oral GLP-1 receptor agonist for type 2 diabetes; and a Nrf2/Bach1 program to reduce oxidative stress and inflammation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full vTv Therapeutics company profile →
Rigel Pharmaceuticals Logo

Rigel Pharmaceuticals

HQ: United States Website
  • Description: Provider of small-molecule drugs for autoimmune, cancer and metabolic diseases, offering REZLIDHIA (olutasidenib) for relapsed/refractory AML with IDH1 mutation and TAVALISSE (fostamatinib) for adult chronic ITP; pipeline includes R289 for LR-MDS, milademetan (MDM2) for liposarcoma with Daiichi Sankyo, bemcentinib (AXL) for NSCLC with BerGenBio, and R552 (RIPK1) for rheumatoid arthritis with Eli Lilly.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rigel Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Alumis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Alumis

2.2 - Growth funds investing in similar companies to Alumis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Alumis

4.2 - Public trading comparable groups for Alumis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Alumis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Alumis

What does Alumis do?

Alumis is a provider of precision medicine solutions focused on the discovery, development, and treatment of autoimmune disorders.

Who are Alumis's competitors?

Alumis's competitors and similar companies include One Lambda, Escient Pharmaceuticals, Septerna, vTv Therapeutics, and Rigel Pharmaceuticals.

Where is Alumis headquartered?

Alumis is headquartered in United States.

How many employees does Alumis have?

Alumis has 1,000 employees 🔒.

When was Alumis founded?

Alumis was founded in 2010 🔒.

What sector and industry vertical is Alumis in?

Alumis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Alumis

Who are the top strategic acquirers in Alumis's sector and industry

Top strategic M&A buyers and acquirers in Alumis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Alumis?

Top strategic M&A buyers groups and sectors for Alumis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Alumis's sector and industry vertical

Which are the top PE firms investing in Alumis's sector and industry vertical?

Top PE firms investing in Alumis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Alumis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Alumis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Alumis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Alumis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Alumis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Alumis?

The key public trading comparables and valuation benchmarks for Alumis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Alumis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Alumis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Alumis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Alumis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Alumis's' sector and industry vertical?

Access recent funding rounds and capital raises in Alumis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Alumis